世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000028185

抗菌薬感受性(AST)試験市場ー2025年までの世界予測

MarketsandMarkets

Antimicrobial Susceptibility Testing Market - Global Forecasts to 2025

発刊日2020/10/01

言語英語

体裁PDF/220ページ

「PDF」版220ページ

0000028185

抗菌薬感受性(AST)試験市場ー2025年までの世界予測
Antimicrobial Susceptibility Testing Market - Global Forecasts to 2025

4,950 USD

※商品のお問い合わせはカートに入れていただくと可能です。

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※販売価格はシングルユーザーライセンスのものとなります。他のライセンス形態・価格に関しましてはご相談下さい。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

抗菌薬感受性(AST)試験市場:製品別(手動、自動感受性試験システム)、種類別(抗菌、抗真菌)、ようとべつ(臨床診断)、方法別(ETEST、ディスク拡散法)、エンドユーザー別∸2025年までの世界予測

抗菌薬感受性(AST)試験市場は2020年における32億ドルから2025年までに42億ドルに達する見込みで、予測期間中のCAGRは5.5%と推定されます。病原性微生物や、細菌性生物の抗生物質耐性につながる抗生物質の使い過ぎによる感染症罹患率の増加、真菌感受性に関するより良い基準の策定、真菌検査のための迅速な商用ASTシステムの使用が増加していることなどがこの市場の主な推進要因です。

COVID-19がAST市場に及ぼす影響

パンデミックの結果、2020年3月から2020年の第2四半期を通して、病院が主にCOVID-19パンデミックへの対応を迫られたことから、(Accelerate Phenoシステム、マイクロスキャンWalkAwayなどの)自動ASTシステムの販売や実装のための顧客へのアクセスが減少しました。現在および今後、顧客へのアクセスが限定されることによって市場プレイヤーが新規ASTシステムの販売を完了し、以前に販売したシステムの実装を行う能力が大幅に削がれるため、使い捨て検査キットの成長が縮小します。さらに、市場は2020年第4四半期までに損失を回復することを期待しています。

レポート詳細

目次

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 27)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
TABLE 1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY USED FOR THE STUDY
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 32)
2.1 RESEARCH DATA
FIGURE 1 GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: RESEARCH METHODOLOGY STEPS
FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Breakdown of primaries
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.1.2.2 Key data from primary sources
2.2 MARKET SIZE ESTIMATION
FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
2.2.1 VENDOR REVENUE-BASED MARKET ESTIMATION
FIGURE 5 VENDOR REVENUE-BASED MARKET ESTIMATION
2.2.2 END USER-BASED MARKET SIZE ESTIMATION
FIGURE 6 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: END USER-BASED ESTIMATION
2.2.3 PRIMARY RESEARCH VALIDATION
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 7 DATA TRIANGULATION METHODOLOGY
2.4 RESEARCH ASSUMPTIONS
2.5 RESEARCH LIMITATIONS

3 EXECUTIVE SUMMARY (Page No. - 44)
FIGURE 8 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION)
FIGURE 9 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SHARE, BY TYPE, 2020 VS. 2025
FIGURE 10 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION)
FIGURE 11 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SHARE, BY METHOD, 2020 VS. 2025 (USD MILLION)
FIGURE 12 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SHARE, BY END USER, 2020 VS. 2025
FIGURE 13 GEOGRAPHICAL SNAPSHOT OF THE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET

4 PREMIUM INSIGHTS (Page No. - 49)
4.1 ANTIMICROBIAL SUSCEPTIBILITY TESTING: MARKET OVERVIEW
FIGURE 14 TECHNOLOGICAL ADVANCEMENTS AND FAVORABLE PRODUCT PIPELINE ARE THE MAJOR FACTORS DRIVING THE GROWTH OF THE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET ACROSS THE GLOBE
4.2 GEOGRAPHIC ANALYSIS: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2020 VS 2025, (USD MILLION)
FIGURE 15 THE AUTOMATED LABORATORY INSTRUMENTS SEGMENT WILL WITNESS HIGH GROWTH IN THE NORTH AMERICA MARKET IN 2025
4.3 MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS MARKET, BY TYPE, 2020 VS 2025, (USD MILLION)
FIGURE 16 THE SUSCEPTIBILITY TESTING DISKS SUBSEGMENT IS EXPECTED TO DOMINATE THE MARKET, BY TYPE, DURING THE FORECAST PERIOD
4.4 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY REGION AND TYPE
FIGURE 17 ANTIFUNGAL SUSCEPTIBILITY TESTING SEGMENT TO REGISTER SIGNIFICANT GROWTH IN THE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET IN EUROPE
4.5 GEOGRAPHIC ANALYSIS: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY METHOD AND REGION, 2020 VS 2025, (USD MILLION)
FIGURE 18 THE AUTOMATED SUSCEPTIBILITY TESTING INSTRUMENTS SEGMENT TO WITNESS HIGH GROWTH IN THE APAC MARKET DURING THE FORECAST PERIOD
4.6 GEOGRAPHIC SNAPSHOT OF THE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET
FIGURE 19 CHINA TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 55)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 20 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Rising incidence of infectious diseases coupled with epidemic & pandemic events
5.2.1.2 Increasing funding, research grants, and public-private investments in the market
5.2.1.3 Technological advancements
5.2.1.4 Growing government initiatives to detect and control antimicrobial-resistant species
5.2.1.5 Emergence of multidrug-resistance due to drug abuse
5.2.2 RESTRAINTS
5.2.2.1 High cost of automated ID/AST systems
5.2.3 OPPORTUNITIES
5.2.3.1 Emerging markets
5.2.3.2 Awareness initiatives for antimicrobial resistance and its control
5.2.4 CHALLENGES
5.2.4.1 Complex regulatory frameworks that delay antimicrobial testing approvals
5.3 IMPACT OF THE COVID-19 ON THE ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET
5.4 ECOSYSTEM ANALYSIS
FIGURE 21 ECOSYSTEM ANALYSIS OF THE OVERALL AST MARKET
5.5 VALUE CHAIN ANALYSIS
FIGURE 22 VALUE CHAIN ANALYSIS: MAXIMUM VALUE-ADDED DURING MANUFACTURING PHASE
5.6 REGULATORY ANALYSIS
5.6.1 NORTH AMERICA
5.6.1.1 US
TABLE 2 US FDA: MEDICAL DEVICE CLASSIFICATION
TABLE 3 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
5.6.1.2 Canada
TABLE 4 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
FIGURE 23 CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES
5.6.2 EUROPE
FIGURE 24 EUROPE: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES (MDR)
5.6.3 ASIA PACIFIC
5.6.3.1 Japan
TABLE 5 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PHARMACEUTICAL AND MEDICAL DEVICE AGENCY (PMDA)
5.6.3.2 China
TABLE 6 CHINA: CLASSIFICATION OF MEDICAL DEVICES
5.6.3.3 India

6 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT (Page No. - 74)
6.1 INTRODUCTION
TABLE 7 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
6.2 MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS
TABLE 8 MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 9 MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.2.1 MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 10 MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS MARKET, 2018-2025 (USD MILLION)
6.2.2 MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 11 MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
6.2.3 MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS MARKET, BY METHOD, 2018-2025 (USD MILLION)
TABLE 12 MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS MARKET, BY METHOD, 2018-2025 (USD MILLION)
6.2.4 MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS MARKET, BY END USER, 2018-2025 (USD MILLION)
TABLE 13 MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS MARKET, BY END USER, 2018-2025 (USD MILLION)
6.2.5 SUSCEPTIBILITY TESTING DISKS
6.2.5.1 Significant adoption of disk diffusion tests in emerging countries to support segment growth
TABLE 14 SUSCEPTIBILITY TESTING DISKS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.2.5.2 Susceptibility testing disks market, by type, 2018-2025 (USD million)
TABLE 15 SUSCEPTIBILITY TESTING DISKS MARKET, BY TYPE, 2018-2025 (USD MILLION)
6.2.5.3 Susceptibility testing disks market, by application, 2018-2025 (USD million)
TABLE 16 SUSCEPTIBILITY TESTING DISKS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
6.2.5.4 Susceptibility testing disks market, by method, 2018-2025 (USD million)
TABLE 17 SUSCEPTIBILITY TESTING DISKS MARKET, BY METHOD, 2018-2025 (USD MILLION)
6.2.5.5 Susceptibility testing disks market, by end user, 2018-2025 (USD million)
TABLE 18 SUSCEPTIBILITY TESTING DISKS MARKET, BY END USER, 2018-2025 (USD MILLION)
6.2.6 MIC STRIPS
6.2.6.1 Growing adoption of broad-spectrum MIC strips to support market growth
TABLE 19 MIC STRIPS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.2.6.2 MIC strips market, by type, 2018-2025 (USD million)
TABLE 20 MIC STRIPS MARKET, BY TYPE, 2018-2025 (USD MILLION)
6.2.6.3 MIC strips market, by application, 2018-2025 (USD million)
TABLE 21 MIC STRIPS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
6.2.6.4 MIC strips market, by method, 2018-2025 (USD million)
TABLE 22 MIC STRIPS MARKET, BY METHOD, 2018-2025 (USD MILLION)
6.2.6.5 MIC STRIPS MARKET, BY END USER, 2018-2025 (USD MILLION)
TABLE 23 MIC STRIPS MARKET, BY END USER, 2018-2025 (USD MILLION)
6.2.7 SUSCEPTIBILITY TESTING PLATES
6.2.7.1 Growing adoption of automated/rapid AST systems is hampering the growth of this segment
TABLE 24 SUSCEPTIBILITY TESTING PLATES MARKET, BY REGION, 2018-2025 (USD MILLION)
6.2.7.2 Susceptibility testing plates market, by type, 2018-2025 (USD million)
TABLE 25 SUSCEPTIBILITY TESTING PLATES MARKET, BY TYPE, 2018-2025 (USD MILLION)
6.2.7.3 Susceptibility testing plates market, by application, 2018-2025 (USD million)
TABLE 26 SUSCEPTIBILITY TESTING PLATES MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
6.2.7.4 Susceptibility testing plates market, by method, 2018-2025 (USD million)
TABLE 27 SUSCEPTIBILITY TESTING PLATES MARKET, BY METHOD, 2018-2025 (USD MILLION)
6.2.7.5 Susceptibility testing plates market, by end user, 2018-2025 (USD million)
TABLE 28 SUSCEPTIBILITY TESTING PLATES MARKET, BY END USER, 2018-2025 (USD MILLION)
6.3 AUTOMATED LABORATORY INSTRUMENTS
6.3.1 THE ONGOING TREND OF LABORATORY AUTOMATION AMONG CLINICAL LABORATORIES WILL FUEL SEGMENT GROWTH
TABLE 29 AUTOMATED LABORATORY INSTRUMENTS MARKET, BY REGION, 2018-2025 (USD MILLION)
6.3.2 AUTOMATED LABORATORY INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 30 AUTOMATED LABORATORY INSTRUMENTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
6.3.3 AUTOMATED LABORATORY INSTRUMENTS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 31 AUTOMATED LABORATORY INSTRUMENTS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
6.3.4 AUTOMATED LABORATORY INSTRUMENTS MARKET, BY METHOD, 2018-2025 (USD MILLION)
TABLE 32 AUTOMATED LABORATORY INSTRUMENTS MARKET, BY METHOD, 2018-2025 (USD MILLION)
6.3.5 AUTOMATED LABORATORY INSTRUMENTS MARKET, BY END USER, 2018-2025 (USD MILLION)
TABLE 33 AUTOMATED LABORATORY INSTRUMENTS MARKET, BY END USER, 2018-2025 (USD MILLION)
6.4 CULTURE AND GROWTH MEDIA
6.4.1 HIGH UTILIZATION OF DISK DIFFUSION AND BROTH DILUTION METHODS TO DRIVE THE SEGMENT GROWTH
TABLE 34 CULTURE AND GROWTH MEDIA MARKET, BY REGION, 2018-2025 (USD MILLION)
6.4.2 CULTURE AND GROWTH MEDIA MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 35 CULTURE AND GROWTH MEDIA MARKET, BY TYPE, 2018-2025 (USD MILLION)
6.4.3 CULTURE AND GROWTH MEDIA MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 36 CULTURE AND GROWTH MEDIA MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
6.4.4 CULTURE AND GROWTH MEDIA MARKET, BY METHOD, 2018-2025 (USD MILLION)
TABLE 37 CULTURE AND GROWTH MEDIA MARKET, BY METHOD, 2018-2025 (USD MILLION)
6.4.5 CULTURE AND GROWTH MEDIA MARKET, BY END USER, 2018-2025 (USD MILLION)
TABLE 38 CULTURE AND GROWTH MEDIA MARKET, BY END USER, 2018-2025 (USD MILLION)
6.5 CONSUMABLES
6.5.1 INCREASING NUMBER OF SUSCEPTIBILITY TESTS PERFORMED AT HOSPITALS TO SUPPORT THE CONSUMABLES SEGMENT
TABLE 39 CONSUMABLES MARKET, BY REGION, 2018-2025 (USD MILLION)
6.5.2 CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 40 CONSUMABLES MARKET, BY TYPE, 2018-2025 (USD MILLION)
6.5.3 CONSUMABLES MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 41 CONSUMABLES MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
6.5.4 CONSUMABLES MARKET, BY METHOD, 2018-2025 (USD MILLION)
TABLE 42 CONSUMABLES MARKET, BY METHOD, 2018-2025 (USD MILLION)
6.5.5 CONSUMABLES MARKET, BY END USER, 2018-2025 (USD MILLION)
TABLE 43 CONSUMABLES MARKET, BY END USER, 2018-2025 (USD MILLION)

7 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY TYPE (Page No. - 97)
7.1 INTRODUCTION
TABLE 44 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY TYPE, 2018-2025 (USD MILLION)
7.2 ANTIBACTERIAL SUSCEPTIBILITY TESTING
7.2.1 THE EMERGENCE OF MULTIDRUG-RESISTANCE TO INCREASE ADOPTION OF ANTIBACTERIAL SUSCEPTIBILITY TESTING PRODUCTS
TABLE 45 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR ANTIBACTERIAL SUSCEPTIBILITY TESTING, BY REGION, 2018-2025 (USD MILLION)
7.3 ANTIFUNGAL SUSCEPTIBILITY TESTING
7.3.1 INCREASING CANDIDA AND ASPERGILLUS SPECIES FUNGAL INFECTIONS ARE MAJOR FACTORS DRIVING SEGMENT GROWTH
TABLE 46 NUMBER OF HOSPITALIZATIONS AND DIRECT MEDICAL COSTS ASSOCIATED WITH FUNGAL DISEASES IN THE UNITED STATES FOR FY 2017
TABLE 47 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR ANTIFUNGAL SUSCEPTIBILITY TESTING, BY REGION, 2018-2025 (USD MILLION)
7.4 ANTIPARASITIC SUSCEPTIBILITY TESTING
7.4.1 RISING INITIATIVES TO CREATE AWARENESS ABOUT PARASITIC INFECTIONS TO DRIVE SEGMENT GROWTH FOR PRODUCTS
TABLE 48 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR ANTIPARASITIC SUSCEPTIBILITY TESTING, BY REGION, 2018-2025 (USD MILLION)
7.5 OTHER SUSCEPTIBILITY TESTING TYPES
7.5.1 COMPLEXITY ASSOCIATED WITH FASTIDIOUS PATHOGEN TESTING TO HAMPER THE GROWTH OF THIS SEGMENT
TABLE 49 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR OTHER SUSCEPTIBILITY TESTING TYPES, BY REGION, 2018-2025 (USD MILLION)

8 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY APPLICATION (Page No. - 103)
8.1 INTRODUCTION
TABLE 50 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
8.2 CLINICAL DIAGNOSTICS
8.2.1 TECHNOLOGICAL ADVANCEMENTS AND INCREASING NUMBER OF SUSCEPTIBILITY TESTS PERFORMED DRIVE SEGMENT GROWTH
TABLE 51 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR CLINICAL DIAGNOSTICS, BY REGION, 2018-2025 (USD MILLION)
8.3 DRUG DISCOVERY AND DEVELOPMENT
8.3.1 RISING ADOPTION OF RAPID AST SOLUTIONS BY BIOPHARMACEUTICAL COMPANIES TO DRIVE SEGMENT GROWTH
TABLE 52 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR DRUG DISCOVERY AND DEVELOPMENT, BY REGION, 2018-2025 (USD MILLION)
8.4 EPIDEMIOLOGY
8.4.1 OUTBREAK OF PANDEMIC AND EPIDEMIC SITUATIONS TO DRIVE DEMAND FOR AST PRODUCTS
TABLE 53 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR EPIDEMIOLOGY, BY REGION, 2018-2025 (USD MILLION)
8.5 OTHER APPLICATIONS
8.5.1 GROWING ADOPTION OF AST PRODUCTS FOR BIOTERRORISM SURVEILLANCE TO FUEL SEGMENT GROWTH
TABLE 54 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR OTHER APPLICATIONS, BY REGION, 2018-2025 (USD MILLION)

9 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY METHOD (Page No. - 109)
9.1 INTRODUCTION
TABLE 55 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY METHOD, 2018-2025 (USD MILLION)
9.2 AUTOMATED ANTIMICROBIAL SUSCEPTIBILITY TESTING INSTRUMENTS
9.2.1 TECHNOLOGICAL ADVANCEMENTS AND FAVORABLE PRODUCT PIPELINE TO DRIVE SEGMENT GROWTH
TABLE 56 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR AUTOMATED ANTIMICROBIAL SUSCEPTIBILITY TESTING INSTRUMENTS, BY REGION, 2018-2025 (USD MILLION)
9.3 DISK DIFFUSION
9.3.1 RISING INCIDENCES OF URINARY TRACT INFECTIONS TO DRIVE SEGMENT GROWTH
TABLE 57 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR DISK DIFFUSION, BY REGION, 2018-2025 (USD MILLION)
9.4 AGAR DILUTION
9.4.1 AGAR DILUTION HELPS EXPLORE DRUG COMBINATIONS FOR COMBINED ANTIBIOTIC THERAPY
TABLE 58 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR AGAR DILUTION, BY REGION, 2018-2025 (USD MILLION)
9.5 ETEST METHOD
9.5.1 UNCERTAINTIES IN RESULT INTERPRETATION HAMPERS THE ADOPTION OF THIS METHOD
TABLE 59 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR ETEST METHOD, BY REGION, 2018-2025 (USD MILLION)
9.6 GENOTYPIC METHODS
9.6.1 ONGOING CLINICAL TRIALS AND UPCOMING PRODUCT LAUNCHES SUPPORT SEGMENT GROWTH
TABLE 60 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR GENOTYPIC METHODS, BY REGION, 2018-2025 (USD MILLION)

10 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER (Page No. - 117)
10.1 INTRODUCTION
TABLE 61 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2018-2025 (USD MILLION)
10.2 HOSPITALS AND DIAGNOSTIC CENTERS
10.2.1 HIGH PREVALENCE OF INFECTIOUS DISEASES COUPLED WITH THE RISING ADOPTION OF RAPID AST SOLUTIONS TO DRIVE SEGMENT GROWTH
TABLE 62 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR HOSPITALS AND DIAGNOSTIC CENTERS, BY REGION, 2018-2025 (USD MILLION)
10.3 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
10.3.1 INCREASING NUMBER OF BIOPHARMACEUTICAL COMPANIES TO SUPPORT SEGMENT GROWTH
FIGURE 25 ANTIMICROBIAL RESISTANCE RELATED R&D PROJECTS BY KEY PLAYERS, 2020
TABLE 63 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2025 (USD MILLION)
10.4 RESEARCH & ACADEMIC INSTITUTES
10.4.1 GROWING RESEARCH GRANTS AND FUNDING IS ACCELERATING THE GROWTH OF THIS SEGMENT
TABLE 64 FUNDING BY THE DEPARTMENT OF HEALTH AND SOCIAL CARE (UK) FOR ANTIMICROBIAL RESISTANCE STUDIES, 2020
TABLE 65 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR RESEARCH AND ACADEMIC INSTITUTES, BY REGION, 2018-2025 (USD MILLION)
10.5 CONTRACT RESEARCH ORGANIZATIONS
10.5.1 CLINICAL TRIAL GLOBALIZATION AND THE GROWING NUMBER OF CROS IN EMERGING ECONOMIES DRIVES MARKET GROWTH
TABLE 66 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2025 (USD MILLION)

11 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY REGION (Page No. - 124)
11.1 INTRODUCTION
TABLE 67 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY REGION, 2018-2025 (USD MILLION)
11.2 NORTH AMERICA
FIGURE 26 NORTH AMERICA: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SNAPSHOT
TABLE 68 NORTH AMERICA: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 69 NORTH AMERICA: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT 2018-2025 (USD MILLION)
TABLE 70 NORTH AMERICA: MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 71 NORTH AMERICA: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 72 NORTH AMERICA: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 73 NORTH AMERICA: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY METHOD, 2018-2025 (USD MILLION)
TABLE 74 NORTH AMERICA: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2018-2025 (USD MILLION)
11.2.1 US
11.2.1.1 The US dominated the North American AST market in 2019
TABLE 75 US: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
TABLE 76 US: MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
11.2.2 CANADA
11.2.2.1 Favorable government initiatives to market growth during the forecast period
TABLE 77 CANADA: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
TABLE 78 CANADA: MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
11.3 EUROPE
TABLE 79 EUROPE: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 80 EUROPE: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT 2018-2025 (USD MILLION)
TABLE 81 EUROPE: MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 82 EUROPE: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 83 EUROPE: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 84 EUROPE: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY METHOD, 2018-2025 (USD MILLION)
TABLE 85 EUROPE: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2018-2025 (USD MILLION)
11.3.1 GERMANY
11.3.1.1 Germany dominated the European antimicrobial susceptibility testing market in 2019
TABLE 86 GERMANY: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
TABLE 87 GERMANY: MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
11.3.2 FRANCE
11.3.2.1 Supportive government policies and easy accessibility to healthcare services to fuel market growth in France
TABLE 88 FRANCE: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
TABLE 89 FRANCE: MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
11.3.3 UK
11.3.3.1 The significant prevalence of infectious diseases coupled with increasing awareness for AST products to drive market growth
TABLE 90 UK: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT. 2018-2025 (USD MILLION)
TABLE 91 UK: MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
11.3.4 ITALY
11.3.4.1 Increasing R&D investments by pharmaceutical companies will propel the demand for AST products in Italy
TABLE 92 ITALY: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
TABLE 93 ITALY: MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
11.3.5 SPAIN
11.3.5.1 Rising geriatric population in Spain to drive market growth for AST procedures
TABLE 94 SPAIN: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
TABLE 95 SPAIN: MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
11.3.6 REST OF EUROPE (ROE)
TABLE 96 ROE: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
TABLE 97 ROE: MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
11.4 ASIA PACIFIC
FIGURE 27 ASIA PACIFIC: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SNAPSHOT
TABLE 98 ASIA PACIFIC: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 99 ASIA PACIFIC: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
TABLE 100 ASIA PACIFIC: MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 101 ASIA PACIFIC: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 102 ASIA PACIFIC: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 103 ASIA PACIFIC: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY METHOD, 2018-2025 (USD MILLION)
TABLE 104 ASIA PACIFIC: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2018-2025 (USD MILLION)
11.4.1 JAPAN
11.4.1.1 Rising initiatives for the development of innovative screening technologies and growing geriatric population to drive market growth in Japan
TABLE 105 JAPAN: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
TABLE 106 JAPAN: MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
11.4.2 CHINA
11.4.2.1 Favorable government regulations and the heavy burden of infectious diseases to drive market growth in China
FIGURE 28 INCIDENTS OF INFECTIOUS DISEASES IN CHINA, 2019
TABLE 107 CHINA: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
TABLE 108 CHINA: MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
11.4.3 INDIA
11.4.3.1 Growing initiatives for clinical diagnosis by the government and major players in the market to drive market growth
TABLE 109 INDIA: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
TABLE 110 INDIA: MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
11.4.4 AUSTRALIA
11.4.4.1 Increasing government funding for research activities to deliver novel products drives the market growth
TABLE 111 AUSTRALIA: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
TABLE 112 AUSTRALIA: MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
11.4.5 SOUTH KOREA
11.4.5.1 The requirement of rapid AMR detection to drive the automated AST systems segment in South Korea
TABLE 113 SOUTH KOREA: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
TABLE 114 SOUTH KOREA: MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
11.4.6 REST OF ASIA PACIFIC
TABLE 115 ROAPAC: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
TABLE 116 ROAPAC: MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
11.5 LATIN AMERICA
TABLE 117 LATIN AMERICA: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
TABLE 118 LATIN AMERICA: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
TABLE 119 LATIN AMERICA: MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 120 LATIN AMERICA: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 121 LATIN AMERICA: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 122 LATIN AMERICA: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY METHOD, 2018-2025 (USD MILLION)
TABLE 123 LATIN AMERICA: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2018-2025 (USD MILLION)
11.5.1 BRAZIL
11.5.1.1 The established presence of major AST product manufacturers drives the market growth in Brazil
TABLE 124 BRAZIL: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
TABLE 125 BRAZIL: MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
11.5.2 MEXICO
11.5.2.1 The growing economic development of the country draws increasing investments, thus driving market growth
TABLE 126 MEXICO: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
TABLE 127 MEXICO: MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
11.5.3 REST OF LATIN AMERICA
TABLE 128 ROLATAM: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
TABLE 129 ROLATAM: MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
11.6 MIDDLE EAST & AFRICA
11.6.1 GROWING INCIDENCE OF INFECTIOUS DISEASES AND LARGE PATIENT POOL TO DRIVE MARKET GROWTH
TABLE 130 MEA: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
TABLE 131 MEA: MANUAL ANTIMICROBIAL SUSCEPTIBILITY TESTING PRODUCTS MARKET, 2018-2025 (USD MILLION)
TABLE 132 MEA: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY TYPE, 2018-2025 (USD MILLION)
TABLE 133 MEA: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
TABLE 134 MEA: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY METHOD, 2018-2025 (USD MILLION)
TABLE 135 MEA: ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET, BY END USER, 2018-2025 (USD MILLION)

12 COMPETITIVE LANDSCAPE (Page No. - 170)
12.1 INTRODUCTION
12.2 MARKET SHARE ANALYSIS
FIGURE 29 GLOBAL ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET SHARE, BY KEY PLAYER, 2019
12.3 COMPETITIVE SCENARIO
12.3.1 PRODUCT LAUNCHES AND APPROVALS
12.3.2 ACQUISITIONS
12.3.3 AGREEMENTS AND COLLABORATIONS
12.3.4 EXPANSIONS

13 COMPANY EVOLUTION MATRIX AND COMPANY PROFILES (Page No. - 174)
13.1 COMPETITIVE EVOLUTION MATRIX AND METHODOLOGY
13.1.1 COMPETITIVE LEADERSHIP MAPPING: MAJOR MARKET PLAYERS (2019)
13.1.1.1 Visionary leaders
13.1.1.2 Innovators
13.1.1.3 Dynamic differentiators
13.1.1.4 Emerging companies
FIGURE 30 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET (GLOBAL) COMPETITIVE LEADERSHIP MAPPING, 2019 (OVERALL MARKET)
13.1.2 COMPETITIVE LEADERSHIP MAPPING: EMERGING COMPANIES/SMES/START-UPS (2019)
13.1.2.1 Progressive companies
13.1.2.2 Starting blocks
13.1.2.3 Responsive companies
13.1.2.4 Dynamic companies
FIGURE 31 ANTIMICROBIAL SUSCEPTIBILITY TESTING MARKET (GLOBAL) COMPETITIVE LEADERSHIP MAPPING, 2019 (SME/START-UPS)
13.2 COMPANY PROFILES
(Business Overview, Products Offered, Recent Developments, MnM View)*
13.2.1 BIOMÉRIEUX SA
FIGURE 32 BIOMÉRIEUX SA: COMPANY SNAPSHOT
13.2.2 BECTON, DICKINSON AND COMPANY
FIGURE 33 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
13.2.3 THERMO FISHER SCIENTIFIC
FIGURE 34 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT
13.2.4 DANAHER CORPORATION
FIGURE 35 DANAHER CORPORATION: COMPANY SNAPSHOT
13.2.5 BIO-RAD LABORATORIES, INC.
FIGURE 36 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT
13.2.6 BRUKER
FIGURE 37 BRUKER: COMPANY SNAPSHOT
13.2.7 ROCHE DIAGNOSTICS
FIGURE 38 ROCHE DIAGNOSTICS: COMPANY SNAPSHOT
13.2.8 MERCK KGAA
FIGURE 39 MERCK KGAA: COMPANY SNAPSHOT
13.2.9 ACCELERATE DIAGNOSTICS, INC.
FIGURE 40 ACCELERATE DIAGNOSTICS, INC.: COMPANY SNAPSHOT
13.2.10 HIMEDIA LABORATORIES
13.2.11 LIOFILCHEM S.R.L.
13.2.12 ALIFAX S.R.L.
13.2.13 CREATIVE DIAGNOSTICS
13.2.14 SYNBIOSIS
13.2.15 BIOANALYSE
13.2.16 OTHER COMPANIES
13.2.16.1 ZHUHAI DL BIOTECH Co., Ltd.
13.2.16.2 ELITechGroup
13.2.16.3 Mast Group Ltd.
13.2.16.4 CONDALAB
13.2.16.5 Genefluidics, Inc.

*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

14 APPENDIX (Page No. - 212)
14.1 DISCUSSION GUIDE
14.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.3 AVAILABLE CUSTOMIZATIONS
14.4 RELATED REPORTS
14.5 AUTHOR DETAILS

この商品のレポートナンバー

0000028185

TOP